Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings

Lancet

Volumn 352, Issue 9138, 1998, Pages 1433-1437

  McCann, U D ^a   Szabo, Z ^b   Scheffel, U ^b   Dannals, R F ^b   Ricaurte, G A ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; CARBON 11; RADIOLIGAND; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN CELL; MALE; NEUROTOXICITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; URINALYSIS;

EID: 0032585201     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)04329-3     Document Type: Article

References (34)

1. 1 Schmidt CJ. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 1987; 240: 1-7.
2. 2 Commins DL, Vosmer G, Virus R, Woolverton W, Schuster C, Seiden L. Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 1987; 241: 338-45.
3. 3H]paroxetine-labelled serotonin uptake sites. J Pharmacol Exp Ther 1987; 242: 911-16.
4. 4 O'Hearn EG, Battaglia G, DeSouza EB, Kuhar MJ, Molliver ME. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 1988; 8: 2788-803.
5. 5 Slikker W, Ali SF, Scallet C, Frith CH, Newport GD, Bailey JR. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Toxicol Appl Pharmacol 1988; 94: 448-57.
6. 6 Ricaurte GA, Forno LS, Wilson MA, et al. (±)3,4-methylenedioxymethamphetamine (MDMA) selectively damages central serotonergic neurons in non-human primates. JAMA 1988; 260: 51-55.
7. 7 Ricaurte GA, DeLanney LE, Irwin I, Langston JW. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 1988; 446: 165-68.
8. 8 Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. J Pharmacol Exp Ther 1989; 249: 713-20.
9. 9 Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn EG, Wilson MA. Neurotoxicity of MDMA and related compounds: anatomic studies. Ann NY Acad Sci 1990; 600: 640-64.
10. 10 Ricaurte GA, Martello AL, Katz JL, Martello MB. Lasting effects of (±)3,4-methylenedioxymethamphetamine on central serotonergic neurons in non-human primates: neurochemical observations. J Pharmacol Exp Ther 1992; 261: 616-22.
11. 11 Fischer CA, Hatzidimitriou G, Katz JL, Ricaurte GA. Reorganization of ascending serotonin axon projections in animals previously exposed to the recreational drug 3,4-methylenedioxymethamphetamine. J Neurosci 1995; 15: 5476-85.
12. 12 Ricaurte GA. Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans. In: Asghar K, DeSouza E, eds. Pharmacology and toxicology of amphetamines and related designer drugs. NIDA Res Monogr 1989; 94: 306-22.
13. 13 Eisner B. Ecstasy: the MDMA Story. Berkeley: Ronin Publishing, 1989.
14. 14 Chappell W, Mordenti J. Extrapolation of toxicological and pharmacological data from animals to humans. In: Tests B, ed. Advances in drug research. San Diego: Academic Press, 1991: 1-116.
15. 15 Ricaurte GA, Finnegan KF, Irwin I, Langston JW. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations. Ann NY Acad Sci 1990; 600: 699-708.
16. 16 McCann UD, Ridenour A, Shaham Y, Ricaurte GA. Serotonin neurotoxicity after MDMA: a controlled study in humans. Neuropsychopharmacology 1994; 10: 129-38.
17. 17 Ricaurte GA, DeLanney LE, Wiener SG, Irwin I, Langston JW. 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates. Brain Res 1989; 474: 359-63.
18. 18 Brewerton TD, Berrettini WH, Nurnberger JI, Linnoila M. Analysis of seasonal fluctuations of CSF monoamine metabolites and neuropeptides in normal controls: findings with 5-HIAA and HVA. Psychiatr Res 1989; 23: 257-65.
19. 19 Dannals RF, Scheffel U, Suehiro M, Ricaurte G. Radioligand development for studying serotonin uptake sites with positron emission tomography. Med Chem Res 1994; 5: 228-44.
20. 11C]McN-5652-Z. J Nucl Med 1993; 34: 120-27.
21. 11C]McN5652. J Cereb Blood Flow Metab 1995; 15: 798-805.
22. 11C]McN5652. Synapse 1995; 20: 37-43.
23. 23 Scheffel S, Szabo Z, Matthews W, Dannals R, Ravert H, Ricaurte G. Fenfluramine-induced loss of serotonin transporters in baboon brain visualized with PET. Synapse 1996; 24: 395-98.
24. 24 Scheffel U, Szabo Z, Mathews WB, et al. In vivo detection of short-and long-term MDMA neurotoxicity: a positron emission tomography study in the living baboon brain. Synapse 1998; 29: 183-92.
25. 11C]McN5652 binding in baboons. Soc Neurosci Abstracts 1997; 23: 558.
26. 11C]McN-5652-Z. J Lab Comp Radiopharm 1992; 31: 841-48.
27. 27 Bergström M, Eriksson L, Bohm C, Blomqvist G, Litton J. Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections. J Comput Assist Tomogr 1983; 7: 42-50.
28. 28 Frey KA, Koeppe RA, Kilbourne MR, et al. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 1996; 40: 873-84.
29. 11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. J Cereb Blood Flow Metab 1996; 16: 1288-99.
30. 30 Muzik O, Chugani D, Chakraborty O, et al. Analysis of C-11 alpha-methyl-tryptophan kinetics for estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab 1997; 17: 659-69.
31. 31 Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. J Soc Industr Appl Math 1963; 11: 431-41.
32. 32 Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical recipes. In: The art of scientific computing. Cambridge, USA: University Press, 1986.
33. 33 Coccaro EF, Murphy DL. Serotonin in Major Psychiatric Disorders. Washington, DC: American Psychiatric Press, 1990.
34. 34 Sandler M, Coppen A, Harnett S. 5-Hydroxytryptamine in psychiatry: a spectrum of ideas. Oxford: Oxford University Press, 1991.